AIM Vaccine Co., Ltd. Class H (6660) Stock Statistics & Valuation Metrics

AIM Vaccine Co., Ltd. Class H has a market cap or net worth of HK$1.88B. The enterprise value is HK$4.06B.

AIM Vaccine Co., Ltd. Class H has 507,673,700 shares outstanding. The number of shares has decreased by -2.65% in one year.

AIM Vaccine Co., Ltd. Class H’s return on equity (ROE) is -0.24 and return on invested capital (ROIC) is -4.16%.

The current PE Ratio of AIM Vaccine Co., Ltd. Class H is ―. AIM Vaccine Co., Ltd. Class H’s PEG ratio is -0.04.

In the last 12 months, AIM Vaccine Co., Ltd. Class H had revenue of 1.15B and earned -675.46M in profits. Earnings per share was -0.55.

In the last 12 months, operating cash flow was 116.22M and capital expenditures -211.78M, giving a free cash flow of -95.56M billion.

AIM Vaccine Co., Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―

AIM Vaccine Co., Ltd. Class H upcoming earnings date is Apr 1, 2027, TBA (Not Confirmed).

AIM Vaccine Co., Ltd. Class H as a current ratio of 0.66, with Debt / Equity ratio of 67.16%

In the past 12 months, AIM Vaccine Co., Ltd. Class H has paid -22.24M in taxes.

AIM Vaccine Co., Ltd. Class H EV to EBITDA ratio is -99.19, with an EV/FCF ratio of -28.67.

AIM Vaccine Co., Ltd. Class H has HK$193.15M in cash and marketable securities with HK$1.77B in debt, giving a net cash position of -HK$1.58B billion.

Gross margin is 65.04%, with operating margin of -18.01%, and net profit margin of -58.51%.

The average price target for AIM Vaccine Co., Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―